SURPASS: ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy
David Hong • 12 Sep 2022
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter